Literature DB >> 2679226

Cytotoxic effector cells of the immune system.

P Groscurth1.   

Abstract

The organism contains several types of cytotoxic cells which are able to lyse host and foreign cells. Cytotoxic T-lymphocytes (CTL) appear to play the most important role among the killer cells but other lymphatic cells, such as natural killer (NK) cells and lymphokine-activated killer (LAK) cells as well as macrophages are also highly effective in the lysis of appropriate targets. The various cytotoxic effector cells differ distinctly concerning origin, phenotype, morphology and target cell specificity, but they bear the common feature that they destroy the target cells in a contact-dependent non-phagocytotic process. CTL are characterized by typical lysosomal granules and by the expression of a characteristic pattern of surface molecules. They recognize specific antigens which are presented in context with molecules of class I major histocompatibility complex (MHC). NK cells, on the other hand, kill the appropriate targets without prior immunisation and without requiring recognition of MHC molecules at the target cells. They also bear a typical pattern of surface markers which differ in several aspects from that of CTL. Human NK cells are further characterized by peculiar cytoplasmic granules with parallel tubular arrays which are not present in other cytotoxic cells. LAK cells constitute an additional, only recently described, killer cell population which arise from lymphatic cells in the presence of interleukin-2. They appear to represent a functional unique cytotoxic effector cell system with an exceptionally wide target cell spectrum including normal and malignant cells of different origin. LAK cells, however, show a profound heterogeneity concerning the expression of phenotype surface markers and it is not yet clear whether they are a unique cell line. By electron microscopy they display peculiar intranuclear inclusion bodies which may be associated with prolonged stimulation by interleukin-2. CTL, NK and LAK cells appear to possess similar mechanisms for cytolysis including secretion of pore-forming proteins, serine proteases and other proteins. Furthermore, they are able to trigger the cleavage of DNA in the target cell nucleus by a hitherto unknown pathway. Macrophages differ substantially from other cytotoxic effector cells concerning morphology, phenotype, kinetic of activation and target cell spectrum. They perform a variety of functions whereby contact-dependent target cell lysis represents only one of their properties. After target cell binding they release over 20 different molecules such as interleukin-1 and tumor necrosis-factor-alpha as mediators for cytolysis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2679226     DOI: 10.1007/bf00309762

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  83 in total

1.  Molecular mechanisms in tumor-cell killing by activated macrophages.

Authors:  D O Adams; C F Nathan
Journal:  Immunol Today       Date:  1983-06

2.  Cell coat, worm-like structures, and labyrinths in guinea pig resident and exudate peritoneal macrophages, as demonstrated by an abbreviated fixation procedure for electron microscopy.

Authors:  P Brederoo; W T Daems
Journal:  Z Zellforsch Mikrosk Anat       Date:  1972

3.  The degree of CTL-induced DNA solubilization is not determined by the human vs mouse origin of the target cell.

Authors:  D M Howell; E Martz
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

4.  Firm persistent binding between activated macrophages and tumor cells is not a prerequisite for the mediation of cytolysis.

Authors:  R Keller; R Keist; P Groscurth
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

5.  Characterization of cloned cytotoxic lymphocytes with NK-like activity.

Authors:  H Acha-Orbea; P Groscurth; R Lang; L Stitz; H Hengartner
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

6.  Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.

Authors:  R Keller; R Keist; P H Van der Meide; P Groscurth; M Aguet; T P Leist
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

7.  Natural killer cell function in human lung is compartmentalized.

Authors:  J C Weissler; L P Nicod; M F Lipscomb; G B Toews
Journal:  Am Rev Respir Dis       Date:  1987-04

8.  Cellular localization of perforin 1 in murine cloned cytotoxic T lymphocytes.

Authors:  P Groscurth; B Y Qiao; E R Podack; H Hengartner
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

9.  Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.

Authors:  N L Vujanovic; R B Herberman; J C Hiserodt
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

10.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma.

Authors:  C F Nathan; T J Prendergast; M E Wiebe; E R Stanley; E Platzer; H G Remold; K Welte; B Y Rubin; H W Murray
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Developmental cell death: morphological diversity and multiple mechanisms.

Authors:  P G Clarke
Journal:  Anat Embryol (Berl)       Date:  1990

Review 2.  Eradicating HIV-1 infection: seeking to clear a persistent pathogen.

Authors:  Nancie M Archin; Julia Marsh Sung; Carolina Garrido; Natalia Soriano-Sarabia; David M Margolis
Journal:  Nat Rev Microbiol       Date:  2014-11       Impact factor: 60.633

3.  Morphological observations on pancreatic islet blood vessels in low-dose streptozocin-treated mice.

Authors:  G Papaccio; T Linn; G Chieffi Baccari
Journal:  J Anat       Date:  1993-02       Impact factor: 2.610

4.  Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.

Authors:  M U Rahman; A Mazumder
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

5.  Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islets of low-dose streptozocin treated mice.

Authors:  G Papaccio; V Esposito
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Changes in Eicosanoid and Tumour Necrosis Factor-alpha Production by Rat Peritoneal Macrophages During Carrageenin-Induced Peritonitis.

Authors:  W M Pruimboom; A Verdoold; C J Tak; A P van Dijk; M van Batenburg; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.